Inflammatory Markers Predicting Pathological Complete Response in Cases with Breast Cancer Treated by Neoadjuvant Chemotherapy.

Büyüksimsek, Mahmut; Ogul, Ali; Mirili, Cem; Paydas, Semra

Büyüksimsek, Mahmut; Ogul, Ali; Mirili, Cem; Paydas, Semra.

Afiliación

Büyüksimsek M; Department of Medical Oncology, Adana City Training and Research Hospital, Adana, Turkey.
Ogul A; Department of Medical Oncology, Adana City Training and Research Hospital, Adana, Turkey.
Mirili C; Department of Medical Oncology, Atatürk University School of Medicine, Erzurum, Turkey.
Paydas S; Department of Medical Oncology, Çukurova University School of Medicine, Adana, Turkey.

Eur J Breast Health ; 16(4): 229-234, 2020 Oct.

Article en En | MEDLINE | ID: mdl-33062961

Palabras clave

Breast cancer; MHR; NLR; PNI; dNLR

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Eur J Breast Health Año: 2020 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Turquía

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google